OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exacerbated pressor and sympathoexcitatory effects of central Elabela in spontaneously hypertensive rats
Zhi Geng, Chao Ye, Ying Tong, et al.
AJP Heart and Circulatory Physiology (2019) Vol. 318, Iss. 1, pp. H124-H134
Open Access | Times Cited: 14
Zhi Geng, Chao Ye, Ying Tong, et al.
AJP Heart and Circulatory Physiology (2019) Vol. 318, Iss. 1, pp. H124-H134
Open Access | Times Cited: 14
Showing 14 citing articles:
Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system
Wei Liu, Jialong Yan, Weinan Pan, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 5, pp. 243-243
Open Access | Times Cited: 77
Wei Liu, Jialong Yan, Weinan Pan, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 5, pp. 243-243
Open Access | Times Cited: 77
Luteolin Attenuates Hypertension via Inhibiting NF-κB-Mediated Inflammation and PI3K/Akt Signaling Pathway in the Hypothalamic Paraventricular Nucleus
Hong‐Li Gao, Xiao‐Jing Yu, Yu‐Qi Feng, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 502-502
Open Access | Times Cited: 28
Hong‐Li Gao, Xiao‐Jing Yu, Yu‐Qi Feng, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 502-502
Open Access | Times Cited: 28
Network pharmacology- and molecular docking-based analyses of the antihypertensive mechanism of Ilex kudingcha
Fei Liao, Muhammad Yousif, Ruya Huang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Fei Liao, Muhammad Yousif, Ruya Huang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects
Chao Ye, Zhi Geng, Lingli Zhang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 10, pp. 2573-2584
Open Access | Times Cited: 22
Chao Ye, Zhi Geng, Lingli Zhang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 10, pp. 2573-2584
Open Access | Times Cited: 22
The Elabela in hypertension, cardiovascular disease, renal disease, and preeclampsia: an update
Chuanming Xu
Journal of Hypertension (2020) Vol. 39, Iss. 1, pp. 12-22
Closed Access | Times Cited: 24
Chuanming Xu
Journal of Hypertension (2020) Vol. 39, Iss. 1, pp. 12-22
Closed Access | Times Cited: 24
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide
Roberto Monastero, Daniele Magro, Marika Venezia, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102076-102076
Open Access | Times Cited: 8
Roberto Monastero, Daniele Magro, Marika Venezia, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102076-102076
Open Access | Times Cited: 8
The network map of Elabela signaling pathway in physiological and pathological conditions
Shobha Dagamajalu, Rex Devasahayam Arokia Balaya, G. P. Suchitha, et al.
Journal of Cell Communication and Signaling (2021) Vol. 16, Iss. 1, pp. 145-154
Open Access | Times Cited: 13
Shobha Dagamajalu, Rex Devasahayam Arokia Balaya, G. P. Suchitha, et al.
Journal of Cell Communication and Signaling (2021) Vol. 16, Iss. 1, pp. 145-154
Open Access | Times Cited: 13
The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect?
Natalia Respekta, Karolina Pich, Monika Dawid, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 150-150
Open Access | Times Cited: 9
Natalia Respekta, Karolina Pich, Monika Dawid, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 150-150
Open Access | Times Cited: 9
Cardiovascular aspects of ELABELA: A potential diagnostic biomarker and therapeutic target
Chuanming Xu
Vascular Pharmacology (2023) Vol. 151, pp. 107193-107193
Closed Access | Times Cited: 5
Chuanming Xu
Vascular Pharmacology (2023) Vol. 151, pp. 107193-107193
Closed Access | Times Cited: 5
The interaction partners of (pro)renin receptor in the distal nephron
Yanting Chen, Chuanming Xu
The FASEB Journal (2020) Vol. 34, Iss. 11, pp. 14136-14149
Closed Access | Times Cited: 12
Yanting Chen, Chuanming Xu
The FASEB Journal (2020) Vol. 34, Iss. 11, pp. 14136-14149
Closed Access | Times Cited: 12
Effects and signaling pathways of Elabela in the cardiovascular system
Meiling Zhou, Yinan Wu
Peptides (2021) Vol. 147, pp. 170674-170674
Closed Access | Times Cited: 11
Meiling Zhou, Yinan Wu
Peptides (2021) Vol. 147, pp. 170674-170674
Closed Access | Times Cited: 11
Advances in the study of ELABELA in renal physiological functions and related diseases
Yurong Liu, MingChun Jiang, Yue Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Yurong Liu, MingChun Jiang, Yue Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Plasma Level of Elabela in Patients with Coronary Heart Disease and Its Correlation with the Disease Classification
Qingping Tian, Meilin Liu, Ya-Rong Zhang, et al.
International Heart Journal (2021) Vol. 62, Iss. 4, pp. 752-755
Open Access | Times Cited: 5
Qingping Tian, Meilin Liu, Ya-Rong Zhang, et al.
International Heart Journal (2021) Vol. 62, Iss. 4, pp. 752-755
Open Access | Times Cited: 5
Elabela Peptide: A New Player in Hypertension and Vascular Damage
Speranza Rubattu
High Blood Pressure & Cardiovascular Prevention (2022) Vol. 30, Iss. 1, pp. 5-6
Closed Access
Speranza Rubattu
High Blood Pressure & Cardiovascular Prevention (2022) Vol. 30, Iss. 1, pp. 5-6
Closed Access
